Formula 745

product on market Capsule DC 🟢 Safety: 100/100
Brand: DC
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
90 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

250 mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 250mg

Other Ingredients

Vegetable Cellulose k-Gelatin Vegetable Magnesium Stearate

Label Claims — Verification

❓ All Other
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 1 capsule three times daily.

⚠️ Warnings & Precautions

Tamper Evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Keep out of reach of children.

Caution: If you are pregnant or nursing do not take this product.

🧪 Formulation Notes

Formula 745 contains Full Spectrum Feverfew Extract (Tanacetum parthenium).

Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs)

Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.

Gluten free

Feverfew Extract 12:1

Made in USA

Additional Information

Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).

New improved formula

Quali Pure

Product Details

DSLD Entry Date 2022-04-11
Product Type Botanical
Form Capsule
Brand DC
DSLD ID 265860
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
PubMed Cochrane
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
PubMed
View all evidence for Feverfew →

Compare Similar Products

Migra-None Douglas Laboratories 100
White Willow Feverfew 350 mg Eclectic Herb 100
Feverfew
Feverfew GNC Herbal Plus Standardized 100
Feverfew Vitabase 100
Feverfew Max-V Douglas Laboratories 100
View all Feverfew products →
Feverfew research & evidence Best Feverfew rankings All Feverfew products More from DC View on NIH DSLD →